慢性肺源性心脏病合并冠心病规范治疗探讨
2016-05-14崔惠康
崔惠康

[摘要] 目的 分析探讨规范治疗对慢性肺源性心脏病合并冠心病患者临床疗效的影响。方法 整群选取2015年1—9月期间来该院接受治疗的慢性肺源性心脏病合并冠心病患者48例,实施规范化治疗,对比实施规范治疗前后的临床疗效,动脉血氧分压(PaO2)、动脉二氧化碳分压(PaCO2)以及临床症状的变化情况。结果 实施规范化治疗后,48例患者中,45例患者病情明显好转。治疗后患者的临床症状明显改缓解,相较于治疗前,治疗后,患者的血气指标动脉血氧分压(PaO2)上升至(69.3±8.4)mmol/L,动脉二氧化碳分压(PaCO2)降低至(47.6±8.7)mmol/L,对比差异有统计学意义(P<0.05)。结论 在对慢性肺原性心脏病合并冠心病患者进行治疗时,采用规范化治疗,可有效改善临床症状,提升临床治疗效果和预后效果。
[关键词] 慢性肺源性心脏病;冠心病;规范治疗;临床应用价值
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2016)03(c)-0040-03
Standard Treatment for Chronic Pulmonary Heart Disease Complicated with Coronary Heart Disease
CUI Hui-kang
Cardiovascular Department, Wanbei Coal-electricity Group General Hospital, Suzhou, Anhui Province, 234099 China
[Abstract] Objective To analyze and investigate the clinical effect of standard treatment on chronic pulmonary heart disease complicated with coronary heart disease. Methods 48 cases with chronic pulmonary heart disease complicated by coronary heart disease underwent standard treatment in our hospital from January 2015 to September 2015 were selected. The clinical efficacy, arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), and clinical symptoms were compared before and after treatment. Results After standard treatment, the disease was improved significantly in 45 cases of the 48 cases, the clinical symptoms relieved obviously. After treatment, the PaO2 increased to(69.3±8.4) mmol/L, PaCO2 reduced to(47.6±8.7) mmol/L from that before treatment respectively (P<0.05). Conclusion In the treatment of chronic pulmonary heart disease complicated with coronary heart disease patients, standard treatment can effectively improve the clinical symptoms and treatment effect and prognosis.
[Key words] Chronic pulmonary heart disease; Coronary heart disease; Standard treatment; Clinical application value
慢性肺源性心脏病简称肺心病,多发于老年群体,发病后,可直接导致患者肺动脉压力升高,致使患者右心室肥大,随着病情的进一步发展,可使患者出现呼吸衰竭、心力衰竭现象,危及患者的生命[1]。冠心病为慢性肺原性心脏病的常见并发症,冠心病的发生,会进一步加大临床治疗难度。该次研究共纳入安徽省宿州市皖北煤电集团总医院心内科2015年1—9月收治的48例慢性肺源性心脏病患者,并对其进行了规范治疗,通过对规范治疗前后临床疗效、血气指标以及患者临床症状变化情况的分析,探讨了规范治疗在慢性肺源性心脏病临床治疗上的应用价值,现报道如下。
1 资料与方法
1.1 一般资料
整群选取来该院接受治疗的48例慢性肺原性心脏病患者为该研究对象,所有患者经临床症状观察、心电图检查以及心衰诊断后,确诊患有慢性肺源性心脏病合并冠心病,排除患有其他严重心、肺疾病患者,心脑血管疾病患者、药物过敏者以及意识障碍者。……
